- Home
- GNLX vs SENS Comparison
GNLX vs SENS Comparison
Compare GNLX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | SENS |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 252.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNLX | SENS |
|---|---|---|
| Price | $4.37 | $6.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $19.75 | ★ $25.58 |
| AVG Volume (30 Days) | 157.5K | ★ 370.3K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | N/A | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $1.99 | $5.25 |
| 52 Week High | $8.54 | $28.00 |
Technical Indicators
Market Signals| Indicator | GNLX | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 51.82 |
| Support Level | $4.10 | $6.03 |
| Resistance Level | $4.37 | $6.95 |
| Average True Range (ATR) | 0.30 | 0.40 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 36.27 | 35.77 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.